Literature DB >> 18287324

Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedure.

Monique A S H Mennink-Kersten1, Dorien Ruegebrink, Rocus R Klont, Adilia Warris, Nicole M A Blijlevens, J Peter Donnelly, Paul E Verweij.   

Abstract

Detection of circulating galactofuranose (galf) antigens, including galactomannan (GM), by the Platelia Aspergillus (PA) enzyme-linked immunosorbent assay (ELISA) is an important tool in the early diagnosis of invasive aspergillosis (IA). We used a modified pretreatment technique (MT) on consecutive negative PA ELISA plasma samples from IA patients in order to improve the detection of the fungal components present. Plasma samples (52) were collected from healthy donors, and 174 plasma samples with a galactomannan index (GMI) below 0.5 were collected from 25 unclassifiable and 23 IA patients. The PA ELISA reactivity of pretreated samples was determined before (conventional technique [CT]) and after (MT) filtration using a Microcon filter with a 50-kDa cutoff (Millipore). For the MT, the sensitivity of the PA ELISA increased from 42.9% (CT) to 78.6% (MT) using a cutoff for the GMI of 1.5 in the probable and proven group, whereas specificity slightly decreased from 98.7% to 96.1% in the control group. The 10-fold concentration step increased the GMI as high as 121-fold. The MT resulted not only in positive reactivity in samples that tested negative with the CT but also in the earlier detection of antigen by 2 to 17 days.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18287324      PMCID: PMC2292900          DOI: 10.1128/JCM.02327-07

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  39 in total

1.  What is the clinical significance of positive blood cultures with Aspergillus sp in hematopoietic stem cell transplant recipients? A 23 year experience.

Authors:  E Simoneau; M Kelly; A C Labbe; J Roy; M Laverdière
Journal:  Bone Marrow Transplant       Date:  2005-02       Impact factor: 5.483

Review 2.  Aspergillus infections in transplant recipients.

Authors:  Nina Singh; David L Paterson
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

3.  Comparison of serum galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis.

Authors:  S Bretagne; J M Costa; E Bart-Delabesse; N Dhédin; C Rieux; C Cordonnier
Journal:  Clin Infect Dis       Date:  1998-06       Impact factor: 9.079

4.  An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group.

Authors:  D W Denning; A Marinus; J Cohen; D Spence; R Herbrecht; L Pagano; C Kibbler; V Kcrmery; F Offner; C Cordonnier; U Jehn; M Ellis; L Collette; R Sylvester
Journal:  J Infect       Date:  1998-09       Impact factor: 6.072

5.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

6.  Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.

Authors:  Carmen Pazos; José Pontón; Amalia Del Palacio
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

7.  Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis.

Authors:  J Maertens; J Verhaegen; H Demuynck; P Brock; G Verhoef; P Vandenberghe; J Van Eldere; L Verbist; M Boogaerts
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

8.  Rat monoclonal antibodies against Aspergillus galactomannan.

Authors:  D Stynen; J Sarfati; A Goris; M C Prévost; M Lesourd; H Kamphuis; V Darras; J P Latgé
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

9.  Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Zekaver Odabasi; Gloria Mattiuzzi; Elihu Estey; Hagop Kantarjian; Fumihiro Saeki; Richard J Ridge; Paul A Ketchum; Malcolm A Finkelman; John H Rex; Luis Ostrosky-Zeichner
Journal:  Clin Infect Dis       Date:  2004-06-28       Impact factor: 9.079

10.  Antigens of Aspergillus fumigatus produced in vivo.

Authors:  J Sarfati; D G Boucias; J P Latgé
Journal:  J Med Vet Mycol       Date:  1995 Jan-Feb
View more
  3 in total

1.  Performance of Galactomannan Antigen, Beta-d-Glucan, and Aspergillus-Lateral-Flow Device for the Diagnosis of Invasive Aspergillosis.

Authors:  Gökhan Metan; Muzaffer Keklik; Gökçen Dinç; Çiğdem Pala; Afra Yıldırım; Berkay Saraymen; Mustafa Yavuz Köker; Leylagül Kaynar; Bülent Eser; Mustafa Çetin
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-09       Impact factor: 0.900

Review 2.  Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome.

Authors:  Richard C Barton
Journal:  Scientifica (Cairo)       Date:  2013-01-14

Review 3.  Chronic Pulmonary Aspergillosis-Where Are We? and Where Are We Going?

Authors:  Gemma E Hayes; Lilyann Novak-Frazer
Journal:  J Fungi (Basel)       Date:  2016-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.